CNSP
CNS Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.92M
P/E Ratio
—
EPS
$-24.12
Beta
0.54
52W High
$13.80
52W Low
$1.90
50-Day MA
$3.47
200-Day MA
$5.73
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About CNS Pharmaceuticals Inc
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-16.62M |
| Operating Margin | 0.00% |
| Return on Equity | -298.60% |
| Return on Assets | -112.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.09 |
| Price-to-Book | 110.38 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.46M |
| Float | $1.45M |
| % Insiders | 0.55% |
| % Institutions | 12.03% |
Historical Volatility
HV 10-Day
62.66%
HV 20-Day
79.67%
HV 30-Day
84.32%
HV 60-Day
88.41%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.00 target)
1
Strong BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026